RT Journal Article
SR Electronic
T1 Normative Values of Echocardiographic Chamber Size and Function in Older Healthy Adults: The Multi-Ethnic Study of Atherosclerosis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.12.05.23299572
DO 10.1101/2023.12.05.23299572
A1 Mukherjee, Monica
A1 Strom, Jordan B.
A1 Afilalo, Jonathan
A1 Hu, Mo
A1 Beussink-Nelson, Lauren
A1 Kim, Jiwon
A1 Addetia, Karima
A1 Bertoni, Alain
A1 Gottdiener, John
A1 Michos, Erin D.
A1 Gardin, Julius M.
A1 Shah, Sanjiv J.
A1 Freed, Benjamin H.
YR 2023
UL http://medrxiv.org/content/early/2023/12/07/2023.12.05.23299572.abstract
AB Background Echocardiographic (2DE) thresholds indicating disease or impaired functional status compared to normal physiologic aging in individuals ≥ 65 years are not clearly defined. In the present study, we sought to establish standard values for 2DE parameters related to chamber size and function in older adults without cardiopulmonary or cardiometabolic conditions.Methods In this cross-sectional study of 3032 individuals who underwent 2DE at Exam 6 in the Multi-Ethnic Study of Atherosclerosis (MESA), 608 participants fulfilled our inclusion criteria, with normative values defined as the mean value ± 1.96 standard deviations and compared across sex and race/ethnicity. Functional status measures included NT-proBNP, 6-minute walk distance [6MWD], and Kansas City Cardiomyopathy Questionnaire [KCCQ]. Prognostic performance using MESA cutoffs was compared to established guideline cutoffs using time-to-event analysis.Results Participants meeting our inclusion criteria (69.5 ± 7.0 years, 46.2% male, 47.5% White) had lower NT-proBNP, higher 6MWD, and higher (better) KCCQ summary values. Women had significantly smaller chamber sizes and better biventricular systolic function. White participants had the largest chamber dimensions, while Chinese participants had the smallest, even after adjustment for body size. Current guidelines identified 81.6% of healthy older adults in MESA as having cardiac abnormalities.Conclusions Among a large, diverse group of healthy older adults, we found significant differences in cardiac structure and function across sexes and races/ethnicities, which may signal sex-specific cardiac remodeling with advancing age. It is crucial for existing guidelines to consider the observed and clinically significant differences in cardiac structure and function associated with healthy aging. Our study highlights that existing guidelines, which grade abnormalities in echocardiographic cardiac chamber size and function based on younger individuals, may not adequately address the anticipated changes associated with normal aging.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicableFunding StatementThe MESA study is supported by contracts: 75N92020D00001, HHSN268201500003I, N01-HC-95159, 75N92020D00005, N01-HC-95160, 75N92020D00002, N01-HC-95161, 75N92020D00003, N01-HC-95162, 75N92020D00006, N01-HC-95163, 75N92020D00004, N01-HC-95164, 75N92020D00007, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute, and by grants UL1-TR-000040, UL1-TR-001079, and UL1-TR-001420 from the National Center for Advancing Translational Sciences (NCATS). Ancillary studies were funded by grants R01-HL127028, R01-HL086719, R01-HL077612, R01-HL075476, and R01-HL098433. MM is funded by the NIH/NHLBI (R01HL162851) and the National Scleroderma Foundation. JBS is supported by the National Institutes of Health (1K23HL144907, R01AG063937), Edwards Lifesciences, Ultromics, HeartSciences, Anumana, and EchoIQ. EM is supported by the Amato Fund for Women?s Cardiovascular Health at Johns Hopkins and American Heart Association grant 946222. AH is supported by NIH/NHLBI R01HL147660. JK is supported by the National Institutes of Health (R01HL159433, R01HL159055, R01HL151686, R01HL154744, and K23HL140092) and the Bruce B. Lerman Clinical Scholar Award. SJS is supported by the National Institutes of Health (R01 HL107577, R01 HL127028, R01 HL140731, and R01 HL149423), the American Heart Association (No. 16SFRN28780016), and research grants from Corvia, AstraZeneca, and Pfizer.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The MESA protocol, information about the source populations from which recruitment occurred, detailed exclusion criteria, investigator contact details, and other information are available at www.mesa-nhlbi.org. Each field side obtained an institutional review board agreement, and all participants provided written consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll MESA data is available by request through www.mesa-nhlbi.org.ABBREVIATIONS, alphabetical order2DETwo-Dimensional Echocardiography6MWDSix-Minute Walk DistanceASEAmerican Society of EchocardiographyAUCArea Under the CurveAVAAortic Valve AreaBMIBody Mass IndexBPMBeats Per MinuteCHSCardiovascular Health StudyCKDChronic Kidney DiseaseCOLColumbia University, New York, NYCOPDChronic Obstructive Pulmonary DiseaseCVDCardiovascular DiseaseeGRFEstimated Glomerular Filtration RateFACFractional Area ChangeHFHeart FailureHTNHypertensionICCIntraclass Correlation CoefficientsIVCInferior Vena CavaJHUJohns Hopkins University, Baltimore, MDKCCQKansas City Cardiomyopathy QuestionnaireLVLeft VentricleLVEFLeft Ventricle Ejection FractionLVOTLeft Ventricular Outflow TrackMESAMulti-Ethnic Study of AtherosclerosisNPVNegative Predictive ValueNT-proBNPN-terminal pro-B-type Natriuretic PeptideNWUNorthwestern University, Chicago, ILPASPPulmonary Artery Systolic PressurePPVPositive Predictive ValueRARight AtriumRVRight VentricleRVSPRight Ventricular Systolic PressureSBPSystolic Blood PressureSDStandard DeviationTAPSETricuspid Annular Plane Systolic ExcursionTDITissue Doppler ImagingTRTricuspid RegurgitationUCLAUniversity of California, Los Angeles, CAUMNUniversity of Minnesota, Minneapolis, MNVTIVelocity Time IntegralWASEWorld Alliance Societies of EchocardiographyWFUWake Forest University, Winston-Salem, NC